For FRLs, AC015908.3 was significantly correlated with survival outcome (P = 1.133e − 06), gender (P = 0.019), tumor stage (P = 1.222e − 04), and tumor T stage (P = 4.68e − 04) (Figures 4(c)–4(f)); LINC01138 was significantly correlated with survival outcome (P = 0.002) and grade (P = 0.002) (Figures 4(g) and 4(h)); LUCAT1 was significantly correlated with survival outcome (P = 0.034), gender (P = 0.010), tumor M stage (P = 0.001), and tumor N stage (P = 5.975e − 04) (Figures 4(i)–4(l)). The gene discussed is LUCAT1; the disease is neoplasm.